Loading
LA
Lipum AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 16 Apr 2025.
Lipum AB (publ): what insiders have been doing
We have very little insider data for Lipum AB (publ) so far: the most recent filing dates from 3 July 2025. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€160,465
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySalePeter Hovstadius1 buy
Financial data
· cache
Last declaration on 3 July 2025
Declarations5 total
9,000 shares@ SEK 2.72100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q428-1
12,000 shares@ SEK 2.72100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q425-1
12,000 shares@ SEK 2.72100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q404-1
9,000 shares@ SEK 2.72100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q402-1
10,755 shares@ SEK 165.9677100.0% of flowAktieISIN SE0015660899FI:A003N409-1
Canonical exit: 15 Jul 2025 (T+90)
5 of 5 declarations
About Lipum AB (publ)
Lipum AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
